米拉贝格朗和普罗皮维林联合治疗耐火性过度活性膀的有效性
Mehmet Gokhan Culha1, Mehmet Ali Sezgin2, Mustafa Erkoc2
1Department of Urology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Türkiye. gokhan_culha64@hotmail.com.
International urogynecology journal
|May 26, 2025
概括
这项研究表明,将mirabegron和propiverine结合起来可以有效地治疗抗其他药物的过度活性膀 (OAB). 该组合改善了大多数患者的OAB症状和生活质量,但副作用是可以控制的.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 过度活跃的膀 (OAB) 是一种以排尿急迫为特征的疾病,通常与频率和夜尿有关.
- 抗胆固醇剂和β-3激动剂是OAB的常见一线治疗方法.
- 很大一部分OAB患者表现出对这些药物单一治疗的耐药性,需要使用替代治疗策略.
研究的目的:
- 评估使用mirabegron和propiverine的联合治疗的疗效和安全性.
- 评估这种组合在OAB耐药的患者标准单疗法 (抗胆固醇药物或β-3激动剂).
主要方法:
- 确定了一组研究队列,包括320名患有OAB症状的患者,这些患者对先前的治疗没有反应.
- 264名患者接受了一年疗程的每日联合mirabegron (50毫克) 和propiverine (30毫克) 治疗.
- 用过度活性膀症状评分 (OABSS) 和膀日记,以及副作用和满意度的评估来衡量患者的结果.
主要成果:
- 一年后,OABSS得分,每日排尿频率,冲动性失禁,夜尿和子使用的显著降低 (p < 0.001).
- 米拉贝格龙+普罗维林组合在改善OAB症状方面表现出62.1%的成功率.
- 最常见的副作用是口腔干燥 (16.3%) 和便秘 (22.3%).
结论:
- 米拉贝格朗加上普罗比维林提供了一种有效且可靠的治疗方法,用于对单一治疗有抗性OAB的治疗.
- 这种组合疗法可能在毒素 (Botox) 应用等干预措施之前成为一种有价值的选择,可能减少对此类程序的需求.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
732
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
732
Drugs for Treatment of Diarrhea-Predominant IBS
636
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
636
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
900
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
900
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
The Micturition Reflex
2.5K
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
2.5K
Cholinergic Antagonists: Therapeutic Uses
1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K


